MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

EMBC — Embecta Corp. Common Stock

Nasdaq

Embecta Corp. Common Stock

CompareBack to Screener
$5.65
-0.14(-2.42%)
O
5.79
H
5.82
L
5.49
V
1.13M
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About EMBC

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateMar 21, 2022
Employees1,850
Stock ExchangeNasdaq
Ticker SymbolEMBC

Key Financial Statistics

Market Cap$320.13M
P/E RatioN/A
Dividend Yield0.71% (Quarterly)
EPSN/A
BetaN/A
52-Week Range$2.77 - $14.91
52-Week Avg Volume1.29M
VWAP$5.64
Transactions11,015
Total Recorded Bars1,138 days